Search

everythinglearnresearchcommunity

for

Search:↓

Australia needs better dermatological guidelines for gender-diverse patients.

Testosterone is important for women's health, but more research is needed to guide its use.

Medical care for transgender youth should be individualized and supportive.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

More research is needed to improve lower body gender affirmation techniques.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Hair transplantation can help transgender patients affirm their gender identity.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

The risks of testosterone implants in women outweigh the benefits.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Transgender and gender-diverse teens need specialized skin and mental health care.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

The best treatment varies per individual, but options include minoxidil, finasteride, PRP, and LLLT.